Sampling plans are widely-recognized as a means to accept “good lots” and reject “bad lots” of materials, components, or finished pharmaceutical products during in-coming, in-process, or final inspections. Often, acceptance sampling plans are inadequate for their intended use, not based on statistically valid rationale, and linked to risk resulting in the acceptance of materials, components, or finished goods that do not meet pre-determined criteria resulting in scrap, rework, complaints, recalls, and regulatory compliance scrutiny. Understanding how these plans are derived and function is crucial to selecting the appropriate acceptance sampling process to minimize the possibility of risk and rework.
This course will expose you to the requirements for acceptance sampling, the correct use of sampling plans, how sampling plans work, various sampling strategies, and understanding the linkage to risk.
At the completion of this session, you will be able to:
This course will be of benefit to anyone working in a GMP regulated environment on global or domestic scale that manages the inspection process including Directors, Managers, Supervisors, Engineers, and Technicians. This includes personnel in the flowing functions:
Physical CD-DVD of recorded session will be despatched after 72 hrs on completion of payment
Recorded video session
Vidia Ramdeen MPA SSBB is a research consultant with experience across a broad array of industries including health care, medical, biomedical, and biotechnology. In addition, his research experience includes strategy, innovation, leadership, solutions-based, and management consulting. His knowledge of compliance issues is a function of consulting responsibilities that provide a fundamental base to analyze today’s complex compliance environment.